This conference in Basel brings together pioneers transforming medicine through CRISPR technology. From groundbreaking therapies to ethical implications, attendees will explore all facets of gene-editing applications. Our team will present cutting-edge research and invite discussions on leveraging CRISPR innovations for broader healthcare impact. Join us to collaborate on pioneering projects that redefine the future of genetic medicine.
Richmond Pharmacology will attend JSCPT 2025 in Tokyo, represented by their leadership team. Topics include early-phase studies, bridging studies between Europe and Asia, gene and RNA-based therapy development, and cross-border collaboration.
By clicking “Accept”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.
.svg){kind=small}
.avif)
